(Q46845159)

Revision as of 07:08, 25 April 2020 by Sic19 (talk | contribs) (‎Created claim: exact match (P2888): https://scigraph.springernature.com/pub.10.1038/sj.leu.2404059, batch #32835)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

English

Genome-wide approach to identify risk factors for therapy-related myeloid leukemia.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Genome-wide approach to identify risk factors for therapy-related myeloid leukemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

1 reference

based on heuristic

author name string

Bogni A

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Cheng C

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Liu W

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Yang W

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Pfeffer J

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Mukatira S

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

French D

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Downing JR

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Pui CH

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

Relling MV

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

20

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

239-246

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404059

0 references

The secondary leukemias: challenges and research directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Topoisomerase II inhibitor-related acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Global gene expression as a function of germline genetic variation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Partial likelihood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation: Table 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Computational comparison of two draft sequences of the human genome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Detection of functional DNA motifs via statistical over-representation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Association of CYP3A4 genotype with treatment-related leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

New light on Myc and Myb. Part II. Myb.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Cooperative binding of c-Myb and Pax-5 activates the RAG-2 promoter in immature B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

The V(D)J recombination activating gene, RAG-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Developmentally controlled and tissue-specific expression of unrearranged VH gene segments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Gene expression profiling of pediatric acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

Identifiers

10.1038/SJ.LEU.2404059

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16341039

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46845159&oldid=1165902899"